The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | M | Musculo-skeletal system | |
| 2 | M05 | Drugs for treatment of bone diseases | |
| 3 | M05B | Drugs affecting bone structure and mineralization | |
| 4 | M05BB | Bisphosphonates, combinations |
| Code | Title | |
|---|---|---|
| M05BB01 | Etidronic acid and calcium, sequential | |
| M05BB02 | Risedronic acid and calcium, sequential | |
| M05BB03 | Alendronic acid and colecalciferol | |
| M05BB04 | Risedronic acid, calcium and colecalciferol, sequential | |
| M05BB05 | ||
| M05BB06 | ||
| M05BB07 | ||
| M05BB08 | ||
| M05BB09 |
| Title | Information Source | Document Type | |
|---|---|---|---|
| FOSAVANCE Tablet | European Medicines Agency (EU) | MPI, EU: SmPC |